Author

Huan He

East China University of Science and TechnologyORCID 0000-0003-2170-4704Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Huan He2 papers · Florida State University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Chang LiuiD· 1 shared Feng Hu· 1 shared Honglin LiiD· 1 shared Kai ZhangiD· 1 shared Kangdong Liu· 1 shared Leihao Zhang· 1 shared Manzhan Zhang· 1 shared Na CheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chang LiuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJun 2, 2025

Contrastive Learning-Enhanced Drug Metabolite Prediction Drives the Discovery of an Orally Bioavailable RSK4 Inhibitor for Esophageal Cancer

Huan He, Manzhan Zhang, Xiaoxiao Yang…·Shiliang Li

The paper develops ConMeter, a metabolite prediction model, and uses it to design an orally bioavailable RSK4 inhibitor with improved bioavailability and anti-tumor efficacy against esophageal cancer.

2 citations

humanmetabolomics

𝕏 PostBluesky